BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31758015)

  • 21. In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon.
    Held J; Zanger P; Issifou S; Kremsner PG; Mordmüller B
    Int J Antimicrob Agents; 2010 Jun; 35(6):587-9. PubMed ID: 20227854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of the in vitro and in vivo efficacy of peptoid-based HDAC inhibitors with dual-stage antiplasmodial activity.
    Mackwitz MKW; Hesping E; Eribez K; Schöler A; Antonova-Koch Y; Held J; Winzeler EA; Andrews KT; Hansen FK
    Eur J Med Chem; 2021 Feb; 211():113065. PubMed ID: 33360801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.
    Trenholme K; Marek L; Duffy S; Pradel G; Fisher G; Hansen FK; Skinner-Adams TS; Butterworth A; Ngwa CJ; Moecking J; Goodman CD; McFadden GI; Sumanadasa SD; Fairlie DP; Avery VM; Kurz T; Andrews KT
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3666-78. PubMed ID: 24733477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
    Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
    Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro sensitivity to antimalarial drugs and polymorphisms in Pfg377 gene in Plasmodium falciparum field isolates from Mewat, India.
    Singh V; Kumar A; Gupta P
    Pathog Glob Health; 2017 Jul; 111(5):225-233. PubMed ID: 28605993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents.
    Vreese R; Kock C; Smith PJ; Chibale K; D'hooghe M
    Future Med Chem; 2017 Mar; 9(4):357-364. PubMed ID: 28263085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
    Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pfcrt 76T and pfmdr1 86Y allele frequency in Plasmodium falciparum isolates and use of self-medication in a rural area of Gabon.
    Mawili-Mboumba DP; Ndong Ngomo JM; Maboko F; Guiyedi V; Mourou Mbina JR; Kombila M; Bouyou Akotet MK
    Trans R Soc Trop Med Hyg; 2014 Nov; 108(11):729-34. PubMed ID: 25249358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
    Schwenke A; Brandts C; Philipps J; Winkler S; Wernsdorfer WH; Kremsner PG
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):63-4. PubMed ID: 11233471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.
    Giannini G; Battistuzzi G; Vignola D
    Bioorg Med Chem Lett; 2015 Feb; 25(3):459-61. PubMed ID: 25563890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.
    Wheatley NC; Andrews KT; Tran TL; Lucke AJ; Reid RC; Fairlie DP
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7080-4. PubMed ID: 20951583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone deacetylase inhibitor AR-42 and achiral analogues kill malaria parasites in vitro and in mice.
    Chua MJ; Tng J; Hesping E; Fisher GM; Goodman CD; Skinner-Adams T; Do D; Lucke AJ; Reid RC; Fairlie DP; Andrews KT
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():118-127. PubMed ID: 34560571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity of Plasmodium falciparum to antimalarial drugs in Hainan Island, China.
    Wang SQ; Wang GZ; Li YC; Meng F; Lin SG; Zhu ZH; Sun DW; He CH; Hu XM; Du JW
    Korean J Parasitol; 2015 Feb; 53(1):35-41. PubMed ID: 25748707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo.
    Borrmann S; Binder RK; Adegnika AA; Missinou MA; Issifou S; Ramharter M; Wernsdorfer WH; Kremsner PG
    Trans R Soc Trop Med Hyg; 2002; 96(6):660-3. PubMed ID: 12625146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of quinolines against Plasmodium falciparum in Gabon.
    Ramharter M; Wernsdorfer WH; Kremsner PG
    Acta Trop; 2004 Mar; 90(1):55-60. PubMed ID: 14739023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J
    Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro tests.
    Aubouy A; Mayombo J; Keundjian A; Bakary M; Le Bras J; Deloron P
    Am J Trop Med Hyg; 2004 Sep; 71(3):294-6. PubMed ID: 15381809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.